LOS ANGELES, Calif., Aug. 11, 2021 (SEND2PRESS NEWSWIRE) — Integrity Bio, Inc., a privately held formulation and fill-finish organization, was sold to Curia (formerly Albany Molecular Research, Inc. (AMRI)), a Contract Development and Manufacturing Organization (CDMO) and leading global provider of advanced contract research, development, and manufacturing solutions. KROST, a Los Angeles-based firm, acted as […]
Archive | Biotechnology
Press Release: Pure Transplant Solutions, LLC Announces Research Collaboration with the Department of Surgery at the University of Cambridge
By Send2Press Newswire on July 21, 2021 in Alliances and Partnerships, AUSTIN, Texas, Biotechnology, Business, Press Releases
AUSTIN, Texas and CAMBRIDGE, U.K., July 21, 2021 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with The University of Cambridge […]
Press Release: BioAustin Appoints New Leadership and Unveils An Expanded Strategic Focus In Central Texas As BioAustinCTX
By Send2Press Newswire on June 3, 2021 in AUSTIN, Texas, Biotechnology, Business, NonProfit and Charities, Press Releases
AUSTIN, Texas, June 3, 2021 (SEND2PRESS NEWSWIRE) — Life Science industry organization BioAustin today announced changes to its leadership team, brand positioning, and long-term strategy focused on facilitating the continued growth of the life science industry in Central Texas. Over the past several years, Austin and the Central Texas region have developed into one of […]
Press Release: Pure MHC, LLC Announces Launch of Contract Research Service Division and Initial Collaboration Project with argenx
By Send2Press Newswire on March 31, 2021 in AUSTIN, Texas, Biotechnology, Business, Press Releases, Product Launches
AUSTIN, Texas, March 31, 2021 (SEND2PRESS NEWSWIRE) — Pure MHC, LLC, a target discovery and development company, today announced the launch of its contract research services arm, Pure MHC Solutions, and an initial collaboration project with global immunology company, argenx.
Press Release: Pure Transplant Solutions Announces Collaboration with Innobiochips to Develop Personalized Diagnostics for Post-Transplant Monitoring and Early Detection of Transplant Rejection
By Send2Press Newswire on March 24, 2021 in Alliances and Partnerships, AUSTIN, Texas, Biotechnology, Business, Press Releases, Surgery and Neurotechnology
AUSTIN, Texas and LOOS, France, March 24, 2021 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with Innobiochips (IBC).
Press Release: Pure Transplant Solutions Announces Collaboration with Northwestern University to Develop Novel Reagents for Enhanced Characterization of HLA DQ Antigens in Transplant Rejection
By Send2Press Newswire on March 17, 2021 in Alliances and Partnerships, AUSTIN, Texas, Biotechnology, Business, Press Releases, Surgery and Neurotechnology
AUSTIN, Texas and EVANSTON, Ill., March 17, 2021 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with Northwestern University, a world […]
Press Release: Pure MHC, LLC Announces Launch of its Peptide HLA Immunotherapy Data Resource following Collaboration with LifeNet Health
By Send2Press Newswire on March 16, 2021 in AUSTIN, Texas, Biotechnology, Business, Drugs and Pharmaceuticals, Press Releases, Product Launches
AUSTIN, Texas, March 16, 2021 (SEND2PRESS NEWSWIRE) — Pure MHC, LLC, a target discovery and development company, today announced the launch of its Peptide HLA Immunotherapy Data Resource (“PHIDR”), built through its collaboration with a trusted provider of transplant solutions and a leader in regenerative medicine, LifeNet Health.
Press Release: Pure Transplant Solutions Announces Collaboration with the University of Alabama at Birmingham to Develop Memory B Cell-Directed Diagnostics for HLA-Sensitized Patients
By Send2Press Newswire on March 11, 2021 in Alliances and Partnerships, Biotechnology, BIRMINGHAM, Ala., Business, Drugs and Pharmaceuticals, Press Releases, Surgery and Neurotechnology
AUSTIN, Texas and BIRMINGHAM, Ala., March 11, 2021 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with The University of Alabama […]
Press Release: Pure Transplant Solutions Announces Collaboration with King’s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease
By Send2Press Newswire on February 24, 2021 in Alliances and Partnerships, AUSTIN, Texas, Biotechnology, Business, Press Releases
AUSTIN, Texas and LONDON, England, Feb. 24, 2021 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with King’s College London.
Press Release: Caisson Biotech, LLC and Heparinex, LLC Announce Positive Examination Report of European Patent and the Discovery of a New Class of Sugar Polymers
By Send2Press Newswire on February 23, 2021 in AUSTIN, Texas, Biotechnology, Business, Drugs and Pharmaceuticals, Patent and Trademark, Press Releases
AUSTIN, Texas and OKLAHOMA CITY, Okla., Feb. 23, 2021 (SEND2PRESS NEWSWIRE) — Caisson Biotech and parent company Heparinex are pleased to announce that they have received a positive examination report from the European Patent Office for a patent covering the chemoenzymatic production of heparosan utilized in the HEPtune® drug delivery platform. Once certified, the new […]